Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 49 min ago
Peer-reviewedCC BY-NC 4.0International Journal of Women's Health

Maternal and Neonatal Outcomes Across Female Genital Mutilation Types in Somalia: An Exploratory Analysis at a Tertiary Referral Hospital

6 affiliations
  1. 1Department of Obstetrics and Gynecology, Mogadishu Somali–Türkiye Recep Tayyip Erdoğan Training and Research Hospital, Mogadishu, Somalia
  2. 2Somali Obstetrics and Gynecology Association (SOGA), Mogadishu, Somalia
  3. 3Department of Emergency Medicine, Mogadishu Somali–Türkiye Recep Tayyip Erdoğan Training and Research Hospital, Mogadishu, Somalia
  4. 4Faculty of Medicine and Health Sciences, Hormuud University, Mogadishu, Somalia
  5. 5Department of Anesthesia and Reanimation, Mogadishu Somali–Türkiye Recep Tayyip Erdoğan Training and Research Hospital, Mogadishu, Somalia
  6. 6Department of Cardiology, Mogadishu Somali–Türkiye Recep Tayyip Erdoğan Training and Research Hospital, Mogadishu, Somalia

Abstract

Background: Type-specific evidence on maternal and neonatal outcomes associated with female genital mutilation (FGM) in Somalia remains limited. We explored selected outcomes in a tertiary referral hospital.

Methods: This exploratory analysis used prospectively collected data from 30 May 2022 through January 2026. Recruitment depended on specialist obstetricians being available or on duty. FGM was assessed by genital examination at admission for delivery after consent. Planned elective cesarean deliveries were excluded. Of 371 cleaned episodes, 337 had documented FGM classification. Type IV was descriptive only. Binary logistic regression compared Types II and III with Type I, adjusting for age and parity, with additional gestational-age adjustment for the neonatal composite.

Results: The classified sample included 23 women without FGM, 60 with Type I, 139 with Type II, 110 with Type III, and five with Type IV. Cesarean delivery was numerically highest in Type II (35.3%); maternal/obstetric complications (19.4%) and stillbirth or early neonatal death (7.3%) were highest in Type III. No statistically significant global differences were detected for these outcomes. No statistically significant adjusted associations were detected for Type II or III vs Type I. In the neonatal logistic model, the adjusted odds ratio per additional gestational week was 0.73 (95% confidence interval 0.64–0.82).

Conclusions: The selected outcomes showed no statistically significant adjusted associations for Types II or III compared with Type I. These exploratory findings do not establish equivalence or estimate FGM-associated risk relative to no FGM. Selection, imprecision, residual confounding, incomplete management data, and outcome-coding limitations constrain interpretation.

Related

  1. Obstetric Hysterectomy at a Greek Tertiary Referral Center: Differences in Maternal and Neonatal Outcomes Between Elective and Urgent Procedures
    Stefanos Flindris, Margioula-Siarkou Chrysoula, Konstantinos Christopoulos +9
    Journal of clinical medicinePeer-reviewedCC BYFull textObstetrics, gynaecology & paediatricsEurope PMCCrossref
  2. Pemphigoid gestationis: A case report on maternal and neonatal outcomes
    Azita Raeisi, Farkhondeh Farzamnia, Leila Bozorgian
    International journal of reproductive biomedicinePeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
  3. Maternal characteristics, clinical indications, and neonatal outcomes in cesarean hysterectomy: A cross-sectional study
    Farahnazsadat Ahmadi, Behnaz Behzadi, Mahboubeh Tajaldini
    International journal of reproductive biomedicinePeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
  4. Comparative Analysis of Maternal and Neonatal Outcomes in Teenage and Adult Pregnancies: A Retrospective Study From Western India
    Sweta Shrivastava, Aadisha Jain, Keisha Goel +1
    CureusPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. Remote monitoring for gestational diabetes: neonatal and maternal outcomes compared to usual care
    Anne-Jet Jansen, Laura Kooij, Lia Wijnberger +3
    BMC MedicinePeer-reviewedCC BY-NC-ND 4.0General medicineCrossref
BibTeX
@article{mohamud2026maternal,
  title = {{Maternal and Neonatal Outcomes Across Female Genital Mutilation Types in Somalia: An Exploratory Analysis at a Tertiary Referral Hospital}},
  author = {Samira Ahmed Mohamud and Mohamed Mukhtar Mohamed and Ali Mohamed Yusuf and Kadri Tezel and Marian Ali Abdi and Ikran Abdirahman Yusuf and Said Abdirahman Ahmed},
  journal = {International Journal of Women's Health},
  year = {2026},
  month = nov,
  doi = {10.2147/ijwh.s650553},
  url = {https://doi.org/10.2147/ijwh.s650553},
  note = {CC BY-NC 4.0},
}
RIS
TY  - JOUR
TI  - Maternal and Neonatal Outcomes Across Female Genital Mutilation Types in Somalia: An Exploratory Analysis at a Tertiary Referral Hospital
AU  - Samira Ahmed Mohamud
AU  - Mohamed Mukhtar Mohamed
AU  - Ali Mohamed Yusuf
AU  - Kadri Tezel
AU  - Marian Ali Abdi
AU  - Ikran Abdirahman Yusuf
AU  - Said Abdirahman Ahmed
PY  - 2026
DA  - 2026/11/01
JO  - International Journal of Women's Health
DO  - 10.2147/ijwh.s650553
UR  - https://doi.org/10.2147/ijwh.s650553
AB  - Background: Type-specific evidence on maternal and neonatal outcomes associated with female genital mutilation (FGM) in Somalia remains limited. We explored selected outcomes in a tertiary referral hospital.  Methods: This exploratory analysis used prospectively collected data from 30 May 2022 through January 2026. Recruitment depended on specialist obstetricians being available or on duty. FGM was assessed by genital examination at admission for delivery after consent. Planned elective cesarean deliveries were excluded. Of 371 cleaned episodes, 337 had documented FGM classification. Type IV was descriptive only. Binary logistic regression compared Types II and III with Type I, adjusting for age and parity, with additional gestational-age adjustment for the neonatal composite.  Results: The classified sample included 23 women without FGM, 60 with Type I, 139 with Type II, 110 with Type III, and five with Type IV. Cesarean delivery was numerically highest in Type II (35.3%); maternal/obstetric complications (19.4%) and stillbirth or early neonatal death (7.3%) were highest in Type III. No statistically significant global differences were detected for these outcomes. No statistically significant adjusted associations were detected for Type II or III vs Type I. In the neonatal logistic model, the adjusted odds ratio per additional gestational week was 0.73 (95% confidence interval 0.64–0.82).  Conclusions: The selected outcomes showed no statistically significant adjusted associations for Types II or III compared with Type I. These exploratory findings do not establish equivalence or estimate FGM-associated risk relative to no FGM. Selection, imprecision, residual confounding, incomplete management data, and outcome-coding limitations constrain interpretation.
SN  - 1179-1411
ER  -